Condition
Adrenocortical Carcinoma|Brain and Central Nervous System Tumors|Head and Neck Cancer|Liver Cancer|Malignant Mesothelioma|Pheochromocytoma|Sarcoma
Estimated Enrollment: 30
Age Group: up to 65 Years (Child, Adult)
Gender: All
Study Type: Interventional
Study Design Allocation: Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: CAN-OTT-9401|CDR0000063892|NCI-V94-0566
Study First Received: November 1, 1999
Last Updated: July 9, 2013
Estimated Primary Completion Date: null
Primary Outcome Measures:
Sponsors and Collaborators:
Ottawa Regional Cancer Centre|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00002608
